{"i":{"hBJTvz69E":{"id":"hBJTvz69E","type":"slide","setup":{"bg":{"selectedKey":"fill","fill":{"opac":1,"rgb":"#fff"},"img":{"filt":{"opac":100,"gray":0,"blur":0,"tint":{"rgb":"#000000","opac":0.8}},"pos":{"type":"crop","fit":{"bg":{"color":{"rgb":"#FFF","opac":100}},"vali":"center","hali":"center"},"crop":{"poi":{"x":552,"y":360}}},"measures":{"size":{"width":1080,"height":720}}}},"transparentBg":{"selectedKey":false},"bord":{"size":0,"rad":0}}},"X_MbL3Ppp8":{"id":"X_MbL3Ppp8","type":"interactive","subtype":"interactiveImage","setup":{"img":{"filt":{"opac":100,"gray":0,"blur":0,"tint":{"rgb":"#FFF","opac":0}},"pos":{"type":"fit","fit":{"bg":{"color":{"rgb":"#c0c5cb","opac":100}},"vali":"center","hali":"center"},"crop":{"poi":{"x":118.5,"y":127.5}},"mask":{"shape":1}},"measures":{"size":{"width":255,"height":255}},"orig":{"rType":"asset","rSubType":"image","fileName":"iconoBLANCObiblio.png","fileSize":4237,"aid":"6aHC6zRHMo","val":"mc-af02a004358a8f0cb7485da7318f00ba.png"}}}},"ZCyBdbBvti":{"id":"ZCyBdbBvti","type":"interactive","subtype":"interactiveRichText","setup":{"frmeTp":{"selectedKey":"noneFrame"},"bg":{"fill":{"opac":0.2,"rgb":"#FFF"}},"txt":{"val":{"ops":[{"insert":"Bibliografia","attributes":{"color":"#1d1d1d","bold":true}},{"insert":"\n","attributes":{"size":"medium"}},{"insert":" ","attributes":{"color":"#1d1d1d","bold":true}},{"insert":"\n","attributes":{"size":"small"}},{"insert":"APOLLONIO, D., PHILIPPS, R., BERO, L., (2016): “Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders”, ","attributes":{"color":"var(--TC2)"}},{"insert":"Cochrane Database Syst Rev","attributes":{"color":"var(--TC2)","italic":true}},{"insert":", 11. CD010274. ","attributes":{"color":"var(--TC2)"}},{"insert":"\n","attributes":{"list":"bullet"}},{"insert":"BALLBÈ, M., GUAL, A., coordinadors. (2012): ","attributes":{"color":"var(--TC2)"}},{"insert":"Guia d’intervenció clínica en el consum de tabac en pacients amb trastorn mental","attributes":{"italic":true,"color":"var(--TC2)"}},{"insert":". Barcelona, Xarxa Catalana d’Hospitals sense Fum, Institut Català d’Oncologia, Departament de Salut de la Generalitat de Catalunya.  ","attributes":{"color":"var(--TC2)"}},{"insert":"\n","attributes":{"list":"bullet"}},{"insert":"DORAN, N., DUBRAVA, S., ANTHENELLI, RM., (2019): “Effects of varenicline, depressive symptoms, and region of enrollment on smoking cessation in depressed smokers”, ","attributes":{"color":"var(--TC2)"}},{"insert":"Nicotine &Tobacco Research","attributes":{"color":"var(--TC2)","italic":true}},{"insert":", 21, pp.156-162. ","attributes":{"color":"var(--TC2)"}},{"insert":"\n","attributes":{"list":"bullet"}},{"insert":"EVINS, AE., BENOWITZ, NL., WEST, R., RUSS, C., McRAE, T., LAWRENCE, D., KRISHEN, A., ST AUBIN, L., MARAVIC, MC., ANTHENELLI, RM., (2019): “Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with psychotic, anxiety, and mood disorders in the EAGLES Trial”, ","attributes":{"color":"var(--TC2)"}},{"insert":"Journal of Clinical Psychopharmacology, ","attributes":{"color":"var(--TC2)","italic":true}},{"insert":"39, pp.108-116.  ","attributes":{"color":"var(--TC2)"}},{"insert":"\n","attributes":{"list":"bullet"}},{"insert":"GRAY, KM., UPADHYAYA, HP., (2009): “Tobacco smoking in individuals with attention-deficit hyperactivity disorder: epidemiology and pharmacological approaches to cessation”. ","attributes":{"color":"var(--TC2)"}},{"insert":"CNS Drugs","attributes":{"color":"var(--TC2)","italic":true}},{"insert":", 23, pp.661-668. ","attributes":{"color":"var(--TC2)"}},{"insert":"\n","attributes":{"list":"bullet"}}]},"rType":"richtext"},"vali":"top","paddV1":10}}},"v":"1"}